ReviewBiomedicines2021

Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease.

Sayali Bhave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.